Bio

Kirsten Lund oversees all financial strategy, planning, and operations for Tissue Regenix. With more than 15 years of finance experience, she brings deep expertise in financial leadership and strategic business growth.

Kirsten joined Tissue Regenix in 2010 and has progressed through several senior roles within the company. She served as Group Financial Controller for three years before being appointed Group Finance Director in November 2019, a position she held until January 2022. She then transitioned to EMEA Director, working closely with the management team to help drive the company’s strategic expansion into new markets.

Drawing on her extensive experience in the healthcare sector, Kirsten provides invaluable insight into company structure and routes to market.

Kirsten holds a Bachelor of Science degree from the University of Derby and achieved her ACCA qualification in 2015.